Osteoporosis after liver transplantation

Liver Transplantation

Volumn 9, Issue 4, 2003, Pages 321-330

  Compston, Juliet E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; CALCITONIN; CALCITRIOL; CALCIUM; CYCLOSPORIN A; CYCLOSPORIN G; ETIDRONIC ACID; FLUORIDE SODIUM; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PAMIDRONIC ACID; RAPAMYCIN; TACROLIMUS; VITAMIN D;

BONE DENSITY; BONE DISEASE; DRUG INFUSION; FRACTURE; GONAD FUNCTION; HUMAN; HYPOGONADISM; INCIDENCE; LIVER TRANSPLANTATION; LOW DRUG DOSE; NONHUMAN; ORGAN TRANSPLANTATION; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; SECONDARY HYPERPARATHYROIDISM; SPINE RADIOGRAPHY; VITAMIN D DEFICIENCY;

EID: 0037387762     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50044     Document Type: Review

References (81)

1. Neuberger J. Liver transplantation. Quart J Med 1999;92:547-550.
2. Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993;94:646-650.
3. Ross PD, Genant HK, Davis JW, Miller PD, Wasnich RD. Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black osteoporotic women. Osteoporos Int 1993;3:120-126.
4. Weaver GA, Franck WA, Streck WF, Starzl TE. Hepatic osteodystrophy after liver transplantation in a patient with primary biliary cirrhosis. Am J Gastroenterol 1983;78:102-106.
5. Haagsma EB, Thijn CJP, Post JG, Slooff MJH, Gips CH. Bone disease after orthotopic liver transplantation. J Hepatol 1988;6: 94-100.
6. Porayko MK, Wiesner RH, Hay JE, Krom RAF, Dickson ER, Beaver S, et al. Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc 1991;23:1462-1465.
7. Eastell R, Dickson ER, Hodgson SF, Wiesner RH, Porayko MK, Wahner HW, et al. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 1991;14:296-300.
8. McDonald JA, Dunstan CR, Dilworth P, Sherbon K, Sheil AGR, Evans RA, et al. Bone loss after liver transplantation. Hepatology 1991;14:613-619.
9. Arnold JC, Hauser D, Ziegler R, Kommerell B, Otto G, Theilmann L, et al. Bone disease after liver transplantation. Transplant Proc 1992;24:2709-2710.
10. Meys E, Fontanges E, Fourcade N, Thomasson A, Pouyet M, Delmas PD. Bone loss after orthotopic liver transplantation. Am J Med 1994;97:445-450.
11. Navasa M, Monegal A, Guanabens N, Peris P, Rimola A, Munoz-Gomez J, et al. Bone fractures in liver transplant patients. Brit J Rheumatol 1994;33:52-55.
12. Ninkovic M, Skingle SJ, Bearcroft PWP, Bishop NJ, Alexander GJM, Compston JE. Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Europ J Gastroenterol Hepatol 2000;12:931-935.
13. Taillandier J, Alemanni M, Samuel D, Bismuth H. Rheumatic complications following liver transplantation. Transplant Proc 1999;31:1717-1718.
14. Hamberg SM, Piers DA, van den Berg AP, Slooff MJH, Haagsma EB. Bone mineral density in the long term after liver transplantation. Osteoporos Int 2000;11:600-606.
15. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, et al. Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 2001;12:484-492.
16. Hawkins FG, Leon M, Lopez MB, Valero MA, Larrodera L, Garcia-Garcia I, et al. Bone loss and turnover in patients with liver transplantation. Hepato-Gastroenterol 1994;41:158-161.
17. Hussaini SH, Oldroyd B, Stewart SP, Roman F, Smith MA, Pollard S, et al. Regional bone mineral density after orthotopic liver transplantation. Europ J Gastroenterol Hepatol 1999;11: 157-163.
18. Ninkovic M, Love S, Tom BDM, Bearcroft PWP, Alexander GJM, Compston JE. Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation. J Hepatol 2002;37:93-100.
19. Leidig-Bruckner G, Hosch S, Dodidou P, Ritschel D, Conradt C, Klose C, et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 2001;357:342-347.
20. Abdelhadi M, Eriksson SA, Eriksson SL, Ericzon BG, Nordenstrom J. Bone mineral status in end-stage liver disease and the effect of liver transplantation. Scand J Gastroenterol 1995;30: 1210-1215.
21. Riemens SC, Oostdijk A, van Doormaal JJ, Thijn CJP, Drent G, Piers DA, et al. Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol. Osteoporos Int 1996;6:213-218.
22. Floreani A, Fries W, Luisetto G, Burra P, Fagiuoli S, Boccagni P, et al. Bone metabolism in orthotopic liver transplantation: a prospective study. Liver Transplant Surg 1998;4:311-319.
23. Crosbie OM, Freaney R, McKenna MJ, Curry MP, Hegarty JE. Predicting bone loss following orthotopic liver transplantation. Gut 1999;44:430-434.
24. Guichelaar M, Hay J, Porayko M, Regan K, Therneau TM, Wiesner R. The long term influence of liver transplantation on bone mineral density of cholestatic patients. Gastroenterology 1999;30:171A.
25. Giannini S, Nobile M, Ciuffreda M, Iemmolo RM, Dalle Carbonare L, Minicuci N, et al. Long-term persistence of low bone density in orthotopic liver transplantation. Osteoporos Int 2000; 11:417-424.
26. Keogh JB, Tsalamandris C, Sewell RB, Jones RM, Angus PW, Nyulasi IB, et al. Bone loss at the proximal femur and reduced lean mass following liver transplantation: a longitudinal study. Nutrition 1999;15:661-664.
27. Feller RB, McDonald JA, Sherbon KJ, McCaughan GW. Evidence of continuing bone recovery at a mean of 7 years after liver transplantation. Liver Transplant Surg 1999;5:407-413.
28. Compston JE. Sex steroids and bone. Physiol Rev 2001;81:419-447.
29. Frost HM. Tetracycline-based histological analysis of bone remodeling. Calcif Tissue Res 1969;3:211-237.
30. Vedi S, Greer S, Skingle SJ, Garrahan NJ, Ninkovic M, Alexander GM, et al. Mechanism of bone loss after liver transplantation: a histomorphometric analysis. J Bone Miner Res 1999;14: 281-287.
31. Shane E, Rivas M, McMahon DJ, Staron RB, Silverberg SJ, Seibel MJ, et al. Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab 1997;82:1497-1506.
32. Välimäki MJ, Kinnunen K, Tähtelä R, Löyttniemi E, Laitenen K, Mäkelä P, et al. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin. Osteoporos Int 1999;10:128-136.
33. Floreani A, Mega A, Tizian L, Burra P, Boccagni P, Baldo V, et al. Bone metabolism and gonad function in male patients undergoing liver transplantation: a two year longitudinal study. Osteoporos Int 2001;12:749-754.
34. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids - potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102:274-282.
35. Weinstein RS, Chen JR, Powers CC, Stewart SA, Landes RD, Bellido T, et al. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 2002;109:1041-1048.
36. Reid IR, Wattie DJ, Evans MC, Stapleton JP. Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 1996; 156:1173-1177.
37. Morris HA, Need AG, O'Loughlin PD, Horowitz M, Bridges A, Nordin BEC. Malabsorption of calcium in corticosteroid-induced osteoporosis. Calcif Tissue Int 1990;46:305-308.
38. Reid IR, Ibbertson HK. Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics. Hormone Metab Res 1987;27:200-204.
39. Sambrook P, Birmingham J, Kempler S, Kelly P, Eberl S, Pocock N et al. Corticosteroid effects on proximal femur bone loss. J Bone Miner Res 1990;5:1211-1216.
40. Van Staa T, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15:993-1000.
41. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, et al. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporin A. Calcif Tissue Int 2001;68:83-86.
42. Goffin E, Devogelaer J-P, Depresseux G, Squifflet JP, Pirson Y. Osteoporosis after renal transplantation. Lancet 2001;357:1623.
43. Diaz-Guerra GM, Gomez R, Jodar E, Loinaz C, Moreno E, Hawkins F. Long-term follow-up of bone mass after orthotopic liver transplantation: effect of steroid withdrawal from the immunosuppressive regimen. Osteoporos Int 2002;13:147-150.
44. Shane E, Rivas M, Staron RB, Silverberg SJ, Seibel MJ, Kuiper J, et al. Fracture after cardiac transplantation: a prospective longitudinal study. J Clin Endocrinol Metab 1996;81:1740-1746.
45. Shane E, Papadopoulos A, Staron RB, Addesso V, Donovan D, McGregor C, et al. Bone loss and fracture after lung transplantation. Transplantation 1999;68:220-227.
46. Cvetkovic M, Mann GN, Romero DF, Liang XG, Ma Y, Jee WSS, et al. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation 1994;57:1231-1237.
47. Aubia J, Masramon J, Serrano S. Bone histology in renal patients receiving cyclosporin. Lancet 1988;1:1048.
48. Bourbigot B, Moal MC, Cleder J. Bone histology in renal transplant patients receiving cyclosporin. Lancet 1988;1048-1049.
49. Romero DF, Buchinsky FJ, Rucinski B, Cvetkovic M, Bryer HP, Liang XG, et al. Rapamycin: a bone sparing immunosuppressant? J Bone Miner Res 1995;10(5):760-768.
50. Compston JE, Greer S, Skingle SJ, Stirling DM, Price C, Friend PJ, et al. Early increase in plasma parathyroid hormone levels following liver transplantation. J Hepatol 1996;25:715-718.
51. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997;60:148-154.
52. Compston JE, Thompson RPH. Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet 1977;i:721-724.
53. Parfitt AM, Gallagher JC, Heaney RP, Johnston CC, Neer N, Whedon GD. Vitamin D and bone health in the elderly. Am J Clin Nutrit 1982;36:1014-31.
54. Compston JE. Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut 1986;27:1073-1090.
55. Crosbie OM, Freaney R, McKenna MJ, Hegarty JE. Bone density, vitamin D status, and disordered bone remodeling in end-stage chronic liver disease. Calcif Tissue Int 1999;64:295-300.
56. Diamond T, Steil D, Lunzer M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut 1990;31:82-87.
57. Ninkovic M, Love S, Tom B.D.M. Alexander GJM, Compston JE. High prevalence of osteoporosis in patients with chronic liver disease prior to transplantation. Calcif Tissue Int 2001;69:321-326.
58. WHO Study group on Osteoporosis. Assessment of fracture risk and its application to postmenopausal osteoporosis. World Health Organ Tech Rep Ser NO 843 1994.
59. Stellon AJ, Webb A, Compston JE, Williams R. Low bone turnover state in primary biliary cirrhosis. Hepatology 1987;7:137-142.
60. Stellon AJ, Webb A, Compston JE. Bone histomorphometry and studies in corticosteroid treated chronic active hepatitis. Gut 1988;29:378-389.
61. Cuthbert JA, Pak CYC, Zerwekh JE, Glass KD, Combes B. Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 1984;4:1-8.
62. Lalor BC, France MW, Adams PH, Counihan TB. Bone and mineral metabolism and chronic alcohol abuse. Quart J Med 1986;59:497-511.
63. Hay JE, Lindor KD, Wiesner RH, Dickson ER, Krom RAF, LaRusso NF. The metabolic bone disease of primary sclerosing cholangitis. Hepatology 1991;14:257-261.
64. Hodgson SF, Dickson ER, Eastell R, Eriksen EF, Bryant HU, Riggs BL. Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis. Bone 1993; 14:819-827.
65. 3 receptor. Biochem Biophys Res Commun 1992;189:1543-1547.
66. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, et al. Increased bone formation in osteocalcin deficient mice. Nature 1996;382:448-452.
67. Wolfhagen FH, van-Buuren HR, den Ouden JW, Hop WC, van Leeuwen JP, Schalm SW, et al. Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study. J Hepatol 1997;26: 325-330.
68. Guanabens N, Pares A, Monegal A, Peris P, Pons F, Alvarez L, et al. Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years. Gastroenterology 1997;113:219-224.
69. Goodman GR, Dissanayake IR, Sodam BR, Gorodetsky E, Lu J, Ma YF, et al. Immunosuppressant use without bone loss-implications for bone loss after transplantation. J Bone Miner Res 2001;16:72-78.
70. Yu X-Z, Carpenter P, Anasetti C. Advances in transplant tolerance. Lancet 2001;357:1959-1963.
71. Valero MA, Loinaz C, Larrodena L, Leon M, Moreno E, Hawkins F. Calcitonin and bisphosphonate treatment in bone loss after liver transplantation. Calcif Tissue Int 1995;57:15-19.
72. Neuhaus R, Lohmann R, Platz KP, Guckelberger O, Schon M, Lang M, et al. Treatment of osteoporosis after liver transplantation. Transplant Proc 1995;27:1226-1227.
73. 3) and its analogs are dose-reducing agents for cyclosporine in vitro and in vivo. Transplant Proc 1994;26:3048-3049.
74. 3 prolongs graft survival without compromising host resistance to infection or bone mineral density. Transplantation 1998;66: 828-831.
75. Hay JE, Malinchoc M, Dickson ER. A controlled trial of calcitonin therapy for the prevention of atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 2001;34:292-298.
76. Reeves HL, Francis RM, Manas DM, Hudson M, Day CP: Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation. Liver Transplant Surg 1998;4:404-409.
77. Bianda T, Linka A, Junga G, Brunner H, Steinert H, Kiowski W, et al. Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate. Calcif Tissue Int 2000;67:116-121.
78. Aris RM, Lester GE, Renner JB, Winders A, Blackwood AD, Lark RK, et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Amer J Resp Crit Care Med 2000;162:941-946.
79. Trombetti A, Gerbase MW, Spiliopoulos A, Slosman DO, Nicod LP, Rizzoli R. Bone mineral density in lung transplant recipients before and after graft: prevention of lumbar spine post-transplantation accelerated bone loss by pamidronate. J Heart Lung Transplant 2000;19:736-743.
80. Fan SL-S, Almond MK, Ball E, Evans K, Cunningham J. Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int 2000;57:684-690.
81. Compston JE. Mechanisms of bone loss and bone gain in untreated and treated osteoporosis. In: Hock J, ed. Osteoporosis. Endocrine 2002;17:21-27. FS